GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

Date:




The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Bunnie Xo Opens Up About Life After Jelly Roll Divorce

Bunnie Xo has a lot going on these days,...

Seahawks’ Bud Clark, Mason Richman out long-term with injuries

Brady HendersonAug 23, 2026, 09:36 PM ETCloseBrady Henderson is...

Oregon quintuple murder suspect found dead in Washington

Suspect found dead after 5 bodies discovered in rural...